You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Implicit Cognition Assessments for Risk of Prescription Opioid Abuse

    SBC: MedicaSafe Inc            Topic: NIDA

    DESCRIPTION provided by applicant This SBIR Phase I application proposes development of MedicaSafeandapos s Implicit Prescription Abuse Cognitive Toolkit IMPACT a technology enabled suite of cognitive assessment tools to significantly add to physiciansandapos ability to detect signs of opioid misuse and abuse in patients on opioid therapies MedicaSafeandapos s IMPACT will comprise prescrip ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  2. A Novel Defined Xenobiotic Free Substrate that Mimics Natural Extracellular Matrix

    SBC: PRIMORIGEN BIOSCIENCES INC.            Topic: 200

    DESCRIPTION provided by applicant Primorigen Biosciences SBIR Proposal Abstract Primorigen Biosciences will develop a defined xenobiotic free synthetic cell culture matrix that fully supports maintenance and directed differentiation of human induced pluripotent stem cells hiPSCs down all three germ layers and dramatically reduces the costs of stem cell culture processes The current most co ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  3. Novel tool for linking drugs and phenotypes

    SBC: GENECENTRIX INC.            Topic: 300

    DESCRIPTION provided by applicant Bringing new drugs to market is a lengthy and expensive endeavor To increase the number of affordable new drugs available to consumers at reasonable costs the efficiency of the drug development process must be greatly improved We aim to develop a novel tool that addresses this challenge by rapid identification of drug targets and drug candidates for any give ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  4. Luminescent metal complex probes for correlative microscopy

    SBC: NANOPROBES INC            Topic: 100

    DESCRIPTION provided by applicant Novel transition metal complex cluster based probes for correlative light and electron microscopy CLEM and universally adoptable robust protocols for labeling whole tissue mounts will be developed The new probes and protocols will enable simultaneous localization of two or more antigens labeled using a single step labeling procedure Following fluorescence ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  5. SpliceCore: A cloud-based platform to detect, quantify and interpret alternative splicing variation from next-generation sequencing data.

    SBC: ENVISAGENICS INC            Topic: 400

    DESCRIPTION provided by applicant This Small Business Innovation Research SBIR Phase I project will yield the first prototype of SpliceCore a cloud based resource for the discovery analysis and interpretation of Alternative Splicing AS from RNA seq data of all known diseases are triggered by defects in AS an mRNA maturation process that conveys functional diversity to genes Defect ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  6. A Novel Device to Monitor and Quantify Early Hypovolemia due to Hemorrhage

    SBC: Simplex Scientific            Topic: 300

    DESCRIPTION provided by applicant Simplex Scientific LLC Simplex is proposing to develop a medical device that can accurately measure hypovolemia due to hemorrhage from trauma which can lead to shock and ultimately death and which will be suitable for deployment at civilian and military trauma sites and during transport where motion induced artifacts interfere with conventional technologies ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Jerry the Bear: A Robotic Platform for At-Home Therapy and Education for Children with Type 1 Diabetes

    SBC: SPROUTEL INC            Topic: 200

    DESCRIPTION provided by applicant The goal of this SBIR Phase I application from Sproutel is to develop a curriculum for providing expert educational content on diabetes self management to be delivered via principles of game based learning in an appealing teddy bear robotic character designed for young children diagnosed with type diabetes mellitus Type diabetes T D affects approximately ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  8. High Resolution Protein Separations via Charged Block Copolymer Membranes

    SBC: TERAPORE TECHNOLOGIES, INC.            Topic: 400

    DESCRIPTION provided by applicant Recent advances in the development of therapeutic biomolecules derived from living organisms or biologics have lead to their widespread applications in the treatment of disease From monoclonal antibodies to recombinant proteins hundreds of biologics are now in the market pipeline As the use of such protein based treatments gains traction the requirements ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Conductive Metallography for Serial Section Electron Microscopy at Nanometer Resolution

    SBC: NANOPROBES INC            Topic: 101

    DESCRIPTION provided by applicant We have discovered a novel method to eliminate specimen charging during scanning electron microscopic examination of tissue specimens using a metallographic staining technique that imparts bulk conductivity to embedded tissue This allows increased beam exposure and dwell time and when used in conjunction with backscatter electron detection and gold nanoparti ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Autism Spectrum Disorder Diagnostic/Therapeutic Agent

    SBC: Spark2Flame, Inc            Topic: 103

    DESCRIPTION provided by applicant Autism Spectrum Disorder ASD is a significant medical problem ASD affects approximately of the population and extracts enormous emotional and financial costs from the afflicted and their families Despite years of research we understand very little about the molecular triggers of ASD and preventative therapeutics remain elusive Recently maternal immune ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government